These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 12093340

  • 1. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
    Veves A, Sheehan P, Pham HT.
    Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.
    Ghatnekar O, Willis M, Persson U.
    J Wound Care; 2002 Feb; 11(2):70-4. PubMed ID: 11901743
    [Abstract] [Full Text] [Related]

  • 3. The healing properties of Promogran in venous leg ulcers.
    Vin F, Teot L, Meaume S.
    J Wound Care; 2002 Oct; 11(9):335-41. PubMed ID: 12430368
    [Abstract] [Full Text] [Related]

  • 4. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.
    Kakagia DD, Kazakos KJ, Xarchas KC, Karanikas M, Georgiadis GS, Tripsiannis G, Manolas C.
    J Diabetes Complications; 2007 Oct; 21(6):387-91. PubMed ID: 17967712
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers.
    Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A.
    Adv Wound Care; 1998 Oct; 11(3):114-9. PubMed ID: 9729942
    [Abstract] [Full Text] [Related]

  • 6. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP, Plosker GL.
    BioDrugs; 2002 Oct; 16(6):439-55. PubMed ID: 12463767
    [Abstract] [Full Text] [Related]

  • 7. Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers.
    Ulrich D, Smeets R, Unglaub F, Wöltje M, Pallua N.
    J Wound Ostomy Continence Nurs; 2011 Oct; 38(5):522-8. PubMed ID: 21860331
    [Abstract] [Full Text] [Related]

  • 8. Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations.
    Wollina U, Schmidt WD, Krönert C, Nelskamp C, Scheibe A, Fassler D.
    Int J Low Extrem Wounds; 2005 Dec; 4(4):214-24. PubMed ID: 16286373
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
    Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H.
    J Diabetes Complications; 2006 Dec; 20(5):329-35. PubMed ID: 16949521
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment.
    Gottrup F, Cullen BM, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson MC.
    Wound Repair Regen; 2013 Dec; 21(2):216-25. PubMed ID: 23438054
    [Abstract] [Full Text] [Related]

  • 11. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR, Reyzelman A, Kawalec J, French M.
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [Abstract] [Full Text] [Related]

  • 12. [Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers].
    Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, Martínez-de-Jesús FR, Aragón-Sánchez FJ.
    Cir Esp; 2007 Jul; 82(1):27-31. PubMed ID: 17580028
    [Abstract] [Full Text] [Related]

  • 13. [Estimation of efficacy of bandage, made of oxidated renewed cellulose with collagen, in the diabetic foot syndrome].
    Horobeĭko MB.
    Klin Khir; 2014 Apr; (4):40-2. PubMed ID: 25097976
    [Abstract] [Full Text] [Related]

  • 14. Application of a collagen matrix dressing on a neuropathic diabetic foot ulcer: a randomised control trial.
    Djavid GE, Tabaie SM, Tajali SB, Totounchi M, Farhoud A, Fateh M, Ghafghazi M, Koosha M, Taghizadeh S.
    J Wound Care; 2020 Mar 02; 29(Sup3):S13-S18. PubMed ID: 32160125
    [Abstract] [Full Text] [Related]

  • 15. Randomized Controlled Trial Comparing Collagen/Oxidized Regenerated Cellulose/Silver to Standard of Care in the Management of Venous Leg Ulcers.
    Cullen BM, Serena TE, Gibson MC, Snyder RJ, Hanft JR, Yaakov RA.
    Adv Skin Wound Care; 2017 Oct 02; 30(10):464-468. PubMed ID: 28914681
    [Abstract] [Full Text] [Related]

  • 16. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes.
    Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, Amery CM, Edmonds ME, Gibby OM, Johnson AB, Jones GR, Masson E, Patmore JE, Price D, Rayman G, Harding KG.
    Health Technol Assess; 2009 Nov 02; 13(54):1-86, iii-iv. PubMed ID: 19922726
    [Abstract] [Full Text] [Related]

  • 17. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.
    Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A.
    Diabetes Care; 2003 Oct 02; 26(10):2853-9. PubMed ID: 14514591
    [Abstract] [Full Text] [Related]

  • 18. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.
    Veves A, Falanga V, Armstrong DG, Sabolinski ML, Apligraf Diabetic Foot Ulcer Study.
    Diabetes Care; 2001 Feb 02; 24(2):290-5. PubMed ID: 11213881
    [Abstract] [Full Text] [Related]

  • 19. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M, de Freitas F, Winter M.
    Ostomy Wound Manage; 2016 Mar 02; 62(3):8-24. PubMed ID: 26978856
    [Abstract] [Full Text] [Related]

  • 20. Apligraf in the treatment of neuropathic diabetic foot ulcers.
    Edmonds M, European and Australian Apligraf Diabetic Foot Ulcer Study Group.
    Int J Low Extrem Wounds; 2009 Mar 02; 8(1):11-8. PubMed ID: 19189997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.